Company intelligence / Profile preview

Zeller Medical

Romanshorn, Thurgau, Switzerland

Ownership: Private
Development stage: Other

Overview

Zeller Medical markets prescription-only herbal medicines for a range of indications that are reimbursed by Swiss basic health insurance. Their products—including those for sleep disorders, depression, PMS, menopause, and allergic rhinitis—are backed by preclinical and clinical research and are sold internationally in over 25 countries.[1]

Therapeutic areas: Women's HealthNeurologyImmunologyPsychiatry
Modalities: Herbal medicinePhytopharmaceutical
Industry: Biotech

Drug pipeline

1 asset

Kadefemin Estriol Ovula

Unknown

Partnerships

Ciba-Geigy (Novartis) (historical R&D collaboration)

Beyond the preview

Go deeper on Zeller Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeller Medical.

Explore the full profile